ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Akari Therapeutics (AKTX) Technical (Analysis) Reports Akari Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Akari Therapeutics (AKTX)

Technical Analysis Report for NASDAQ stock AKTX Akari Therapeutics. Dated: 04 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock AKTX Akari Therapeutics then click here. or read Experts views on Akari Therapeutics or Forecast & share price targets of Akari Therapeutics

Akari Therapeutics Opened at 0.25 and Closed at: 0.25, which is 8% of previous session's close. It moved within a range of 0.24 and 0.26
The session was a Neutral session with an average volume of 441800, which is 46.42% of previous session's volumes.

    A Golden cross was found 4 days back on short term averages

    Support for tomorrow is 0.24 and resistance for tomorrow is 0.26
    These support and resistance points are valid for the first 5-15 minutes charts

    Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

    Support for tomorrow's hourly charts is 0.24, 0.23 resistance for tomorrow's hourly charts is 0.26, 0.27

    10 Day SMA for Akari Therapeutics (AKTX) is 0.25 and stock is trading above these levels. This is a good sign for its short term trend

    20 Day SMA for Akari Therapeutics (AKTX) is 0.24 and the stock is trading above these levels. This is a good sign for its mid term trend

    50 Day SMA for Akari Therapeutics (AKTX) is 0.26 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

    100 Day SMA is 0.41 and the stock is trading below these levels. This is not a good sign for its long term trend

    200 Day SMA Akari Therapeutics is 0.73 and stock is trading below these levels. This is not a good sign for its long term trend

    20 DMA of Akari Therapeutics is at 0.24 and 200 DMA is at 0.73, while 50 DMA and 100 DMA are at 0.26 and 0.41 respectively

    Akari Therapeutics (AKTX) moving average of 20 SMA is at 0.24 and 20 EMA is at 0.28

    Akari Therapeutics (AKTX) moving average of 50 SMA is at 0.26 and 50 EMA is at 0.35

    Akari Therapeutics (AKTX) moving average of 100 SMA is at 0.41 and 100 EMA is at 0.48

    Akari Therapeutics (AKTX) moving average of 200 SMA is at 0.73 and 200 EMA is at 0.73

    Akari Therapeutics has performed better than Neuronetics Inc in short term. Holding Akari Therapeutics could be a better choice for now!

    Akari Therapeutics has performed better than Sarepta Therapeutics in short term. Holding Akari Therapeutics could be a better choice for now!

    Sangamo Therapeutics has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Sangamo Therapeutics, about 5.59% more returns!

    Akari Therapeutics has performed better than Ptc Therapeutics in short term. Holding Akari Therapeutics could be a better choice for now!

    Akari Therapeutics has performed better than Nucana Plc in short term. Holding Akari Therapeutics could be a better choice for now!

    Akari Therapeutics has performed better than Medpace Holdings in short term. Holding Akari Therapeutics could be a better choice for now!

    Karyopharm Therapeutics has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Karyopharm Therapeutics, about 41.55% more returns!

    Akari Therapeutics has performed better than Heron Therapeutics in short term. Holding Akari Therapeutics could be a better choice for now!

    Galectin Therapeutics has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Galectin Therapeutics, about 1.19% more returns!

    Akari Therapeutics has performed better than Amicus Therapeutics in short term. Holding Akari Therapeutics could be a better choice for now!

    Akari Therapeutics has performed better than Fulgent Genetics in short term. Holding Akari Therapeutics could be a better choice for now!

    Editas Medicine has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Editas Medicine, about 23.23% more returns!

    Akari Therapeutics has performed better than Alkermes Plc in short term. Holding Akari Therapeutics could be a better choice for now!

    Akari Therapeutics Technical analysis of indicators

    Price action analysis of Akari Therapeutics (AKTX) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

    ADX buy sell signal for Akari Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

    MACD generated a BUY signal for Akari Therapeutics in short term but the buy signal is initial and weak.

    Akari Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!

    Ichimoku cloud is of red color Prices appear to be moving up

    CCI has generated a buy signal for Akari Therapeutics in short term and BUY signal is strong.

    RSI is generating a SELL signal in short term and selling is picking up momentum.

    MRSI is in negative zone. This is the SELL zone

    Although the stock is in the SELL zone, but selling might be slowing down

    Stock of Akari Therapeutics is picking up selling momentum according to indicator.

    Volume based indicators are showing selling momentum.

    Volume Weighted Averaged Price (VWAP) for short term is 0.25 and Akari Therapeutics AKTX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

    People seem to be coming out and selling the Akari Therapeutics AKTX stock. Volume based technical analysis of Akari Therapeutics AKTX stock is negative.

    Akari Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

    Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

    Tomorrow's Predictions

    You should also read Tomorrow's Movement Predictions for NASDAQ stock AKTX Akari Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

    And AKTX Experts View which covers a lot of information including buying and selling signals

    AKTX future forecast & share price targets

    You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Akari Therapeutics or View Candle Stick Charts here

    Chart Akari Therapeutics (AKTX)  Technical (Analysis) Reports Akari Therapeutics [

    Videos related to: Akari Therapeutics (AKTX) Technical (Analysis) Reports Akari Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

    Hindi Basics How To Trade In FnO Futures Options Stock Market

    Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

    Akari Therapeutics (AKTX)  Technical (Analysis) Reports Akari Therapeutics [

     

    Back to top